Key result
Rituximab linked to rapid hypoxemia improvement in pulmonary intravascular lymphoma.
Why the study?
Pulmonary intravascular lymphoma is a rare aggressive lymphoma subtype causing hypoxemia, and effective treatments for rapid improvement are not well established.
Does rituximab improve hypoxemia in patients with pulmonary intravascular lymphoma?
Does rituximab improve hypoxemia in patients with pulmonary intravascular lymphoma?
Rituximab may rapidly improve hypoxemia in patients with pulmonary intravascular lymphoma.
Answers are grounded in this paper and cite their sources.
May support rituximab for hypoxemia in pulmonary intravascular lymphoma; hypothesis-generating, needs prospective validation.
Intravascular lymphoma (IVL) is an uncommon subtype of aggressive extranodal non-Hodgkin's lymphoma (NHL) characterized by the occlusion of small vessels by lymphoma cells throughout the body by ly...
No takes yet. Share an insight, caveat, or question.
Matsue et al. (2006) studied this question. Rituximab rapidly improved hypoxemia in patients with pulmonary intravascular lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: